Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2148 results about "Gastrointestinal tract" patented technology

The gastrointestinal tract (digestive tract, digestional tract, GI tract, GIT, gut, or alimentary canal) is an organ system within humans and other animals which takes in food, digests it to extract and absorb energy and nutrients, and expels the remaining waste as feces. The mouth, esophagus, stomach and intestines are part of the gastrointestinal tract. Gastrointestinal is an adjective meaning of or pertaining to the stomach and intestines. A tract is a collection of related anatomic structures or a series of connected body organs.

Suction stent

A stent for introduction into a hollow organ, in particular the gastrointestinal tract, of a human or animal patient, is to provide a vacuum sealing of leaks to a particular anatomic region in the hollow organ. The stent has a radially expandable body having a wall defining an inner fluid passageway from one end to a longitudinally opposing end, a liquid-tight and flexible first layer covering the walls surface along its entire circumference and along a first predefined region in the longitudinal direction, and a resilient porous second layer covering an outer surface of the wall along its entire circumference and along a second predefined region in the longitudinal direction and at least partially covering the first layer. The first layer is arranged at the wall surface and extends at least partially through the wall in a radial direction and / or the second layer is mechanically secured to the body.
Owner:VAC STENT GMBH

Five-union bacteria for conditioning and improving diarrhea, constipation and irritable bowel syndrome

The invention discloses a quintuple bacterium for conditioning and improving diarrhea, constipation and irritable bowel syndrome. The quintuple bacteria comprise lactobacillus reuteri HBM11-69, pediococcus pentosaceus MPL5, lactobacillus plantarum La-10, lactobacillus rhamnosus HBM11-35 and lactobacillus casei C7-2 bacteria, and the lactobacillus rhamnosus HBM11-35, the pediococcus pentosaceus MPL5, the lactobacillus plantarum La-10, the lactobacillus rhamnosus HBM11-35 and the lactobacillus The strain is found by a Lin Junjunch Teaching Team of South China Agricultural University. The probiotic composition disclosed by the invention is mutually matched and has a synergistic effect, and the intestinal flora structure balance can be effectively recovered by improving the small intestine propulsion rate, reducing the diarrhea frequency and the like. No matter in a viable or inactivated state, the traditional Chinese medicine composition has a relatively good improvement effect on gastrointestinal discomfort such as constipation and irritable bowel syndrome. The quintuplet compound probiotics are high in safety, do not cause adverse reactions such as electrolyte imbalance and can be used for preparing medicines or health foods or foods.
Owner:JIANMA PHARM (GUANGDONG) CO LTD

Lactobacillus kefiranofaciens IMAU12319 and application thereof

The invention discloses lactobacillus kefiranofaciens IMAU12319 and application thereof, belongs to the technical field of microorganisms, and particularly relates to lactobacillus kefiranofaciens IMAU12319 which is preserved in China General Microbiological Culture Collection Center (CGMCC) on July 8, 2024, the preservation address is No. 3, No.1 yard, West Beichen Road, Chaoyang District, Beijing, and the number is CGMCC No.31224. The lactobacillus kefiranofaciens IMAU12319 has the advantages that the lactobacillus kefiranofaciens IMAU12319 can be used for preparing the lactobacillus kefiranofaciens IMAU12319, and the lactobacillus kefiranofaciens IMAU12319 can be used for preparing the lactobacillus kefiranofaciens IMAU12319; the invention also relates to an application of the lactobacillus kefiranofaciens IMAU12319 in preparation of a probiotic agent capable of resisting gastrointestinal digestion. The strain disclosed by the invention not only shows good gastrointestinal tract endurance capacity, but also shows relatively strong potential in the aspects of intestinal adhesion, oxidation resistance and bacteriostasis, and has a wide application prospect in leavening agent strains.
Owner:INNER MONGOLIA AGRICULTURAL UNIVERSITY

Screening and preparation method and application of horse milk whey protein source antioxidant peptide

The invention relates to a method for screening and preparing a horse milk whey protein source antioxidant peptide and application of the horse milk whey protein source antioxidant peptide. The polypeptide with potential antioxidant activity is screened out by predicting information of the polypeptide through virtual enzymolysis and a computer and then performing molecular docking with the keap1 protein. The feasibility of obtaining the antioxidant peptide is verified by simulating gastrointestinal digestion with pepsin, trypsin and chymotrypsin. Finally, in-vitro chemical antioxidant activity verification is carried out through chemical synthesis of the high-purity antioxidant peptide, and it is found that the antioxidant peptide has good free radical scavenging activity. An oxidative damage model is induced by H2O2 on cells, and it is found that the antioxidant peptide can resist cell oxidative damage by exciting the activity of a series of antioxidant enzymes. The natural antioxidant peptide screened by the invention has wide application prospects in the fields of foods, medicines, cosmetics and the like, and an efficient way is provided for development of horse milk whey protein source functional polypeptide products.
Owner:CHINA AGRI UNIV

Lactobacillus mucilaginosus and application thereof

The invention discloses a lactobacillus mucus fermentation strain and application thereof, and provides a lactobacillus mucus fermentation strain A10 with high yield of exopolysaccharides, and the preservation number of the lactobacillus mucus fermentation strain A10 is CCTCC (China Center for Type Culture Collection) NO: M20242082. The fermented lactobacillus mucus A10 has relatively strong bile salt and gastrointestinal tract digestion tolerance and has an obvious antibacterial effect on escherichia coli and staphylococcus aureus, and the exopolysaccharide synthesized by the fermented lactobacillus mucus A10 is Wzy type exopolysaccharide, is heteropolysaccharide composed of rhamnose, galactose, glucose, mannose and glucuronic acid, and can be used for preparing the exopolysaccharide. The product has good thermal stability and antioxidant activity, and can significantly scavenge free radicals. The lactobacillus mucus A10 extracellular polysaccharide provided by the invention can exert antioxidant activity by activating a Keap1-Nrf2 / ARE signal channel, and is expected to be developed into a natural antioxidant which interacts with Keap1-Nrf2 in a targeting manner.
Owner:YUNNAN AGRICULTURAL UNIVERSITY

Hippocampus-derived neuroprotective and anti-oxidative stress polypeptide and preparation method thereof

The invention relates to the technical field of hippocampus extract, in particular to a hippocampus-sourced neuroprotection and anti-oxidative stress polypeptide and a preparation method thereof.The amino acid sequence of the polypeptide is shown as SEQ ID No.1. The preparation method comprises the following steps that 1, 500 g of fresh hippocampus is weighed, surface silt is removed, freeze-drying is conducted at the temperature of-60 DEG C, then the hippocampus is smashed through a smashing machine and sieved through a 20-mesh sieve, and the hippocampus extract is obtained; dialyzing with distilled water for 24 hours, and freeze-drying to obtain hippocampus powder; (2) weighing 200g of hippocampus powder, adding 1000ml of 95% ethanol, extracting for three times, removing fat-soluble substances, and extracting and freeze-drying precipitates by using a 1 mol / L NaCl solution under the condition of 4 DEG C in combination with ultrasonic assistance to obtain crude hippocampus protein; (3) the hippocampus crude protein is taken, the hippocampus polypeptide is prepared through an ultrasonic-assisted bionic digestion method, and the hippocampus polypeptide has the advantages of being specific in molecular structure, clear in action mechanism, stable in gastrointestinal tracts, capable of protecting nerves, resistant to oxidative stress and the like.
Owner:WEIHAI MARINE BIOMEDICAL IND TECH RES INST CO LTD

CT image segmentation and classification system based on class activation graph guidance

The invention belongs to the technical field of medical image processing, and particularly discloses a CT image segmentation and classification system based on class activation graph guidance, and the specific technical scheme is that the system constructs three functional complementary segmentation and classification networks of a coarse segmentation network, a classification network and a fine segmentation network; according to the method, collaborative optimization and performance improvement of classification and segmentation tasks are realized, a closed-loop optimization process is formed by a multi-task collaborative mechanism, and a bidirectional optimization path of segmentation guide classification and classification feedback segmentation is constructed by utilizing internal correlation existing in the segmentation and classification tasks; a coarse segmentation result containing tumor position information is used for enhancing the tumor discrimination capability of a classification network, a class activation graph generated by the classification network is converted into a spatial position weight, the segmentation network is guided to pay attention to a focus area with discrimination, a finer segmentation mask is generated, and through bidirectional information interaction, the tumor discrimination capability of the classification network is improved. The two dimensions of precise positioning and pathological discrimination of gastrointestinal tumors are remarkably improved.
Owner:SHANXI UNIV OF CHINESE MEDICINE +1

Multifunctional compound probiotic composition and preparation process thereof

The invention relates to the technical field of microorganisms, and discloses a multifunctional compound probiotic composition which comprises the following raw materials in percentage by mass: 40-50% of probiotics; 30%-40% of a microcapsule embedding material; prebiotics: 10%-25%; 1%-5% of auxiliary materials; the invention also provides a preparation process of the multifunctional compound probiotic composition. The preparation process comprises the following steps: S1, culturing the probiotics and detecting the activity; s2, a microencapsulation process: preparing a multi-layer microcapsule through a spray drying method and an emulsion crosslinking method, and embedding the probiotics; and S3, mixing the microcapsules with prebiotics and auxiliary materials to obtain the multifunctional compound probiotic composition. By adopting a composite probiotic compatibility technology and through the synergistic effect of different strains, the stability and functionality of intestinal microecology are enhanced, and the effects of improving the survival rate of probiotics in gastrointestinal tracts, promoting planting of beneficial bacteria and enhancing the immunoregulation ability are achieved.
Owner:TIANJIN YOUJIN BIOTECHNOLOGY CO LTD

Sea cucumber protein heptapeptide with functions of reducing blood pressure and blood sugar and application of sea cucumber protein heptapeptide

The invention discloses a sea cucumber protein heptapeptide with functions of reducing blood pressure and blood sugar and application of the sea cucumber protein heptapeptide, and belongs to the technical field of bioactive peptide biology. The amino acid sequence of the sea cucumber protein heptapeptide is LPPGPFP. The sea cucumber protein heptapeptide can significantly inhibit the activity of ACE through a competitive inhibition mode, tolerates the gastrointestinal tract digestion environment, also has DPP-IV inhibition activity, can relieve hypertension and type 2 diabetes mellitus at the same time, and has an application value in preparation of products with the efficacy of reducing blood pressure and blood sugar due to multiple functions of the sea cucumber protein heptapeptide. The sea cucumber protein heptapeptide provided by the invention can significantly inhibit the activity of ACE through a competitive inhibition mode, has DPP-IV inhibition activity, has the characteristics of simple structure, safety, strong activity and the like, and has a wide application prospect.
Owner:SHANDONG QIMAN BIOTECHNOLOGY CO LTD

Chemical ablation and method of treatment for various diseases

To provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue.SOLUTION: In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion or a suspension of one or more ingredients. In embodiments of the present invention, amounts of the formulation and / or energy are effective in injuring or damaging tissue, nerves and nerve endings in order to relieve disease symptoms.SELECTED DRAWING: Figure 3B
Owner:NEUROTRONIC INC

Medical image segmentation method and system based on spatial detail enhanced vision

The invention provides a medical image segmentation method and system based on spatial detail enhanced vision, and relates to the technical field of image processing. The method comprises the following steps: performing initial feature mapping on an input and preprocessed medical image to obtain an embedded feature map; the embedded feature map is input into an encoder for feature extraction, and multi-scale features are obtained; the encoder comprises a plurality of encoding stages, and the number of channels is doubled and the spatial resolution is halved through down-sampling operation between the encoding stages; the multi-scale features are subjected to up-sampling and spatial enhancement reconstruction step by step through a decoder, and a high-precision segmentation result is generated; wherein the decoder comprises a plurality of decoding stages, the decoding stages correspond to the encoding stages, and feature fusion is carried out between the corresponding stages of the encoder and the decoder through jump connection. According to the method, the boundary description precision and the segmentation robustness of the low-contrast image can be improved without increasing the linear complexity, and the method is suitable for medical image segmentation scenes of skin lesions, gastrointestinal polyps and the like.
Owner:XIAMEN UNIV OF TECH

Microneedle drug administration apparatus and preparation method therefor

The present disclosure relates to the technical field of drug delivery, and in particular, to a microneedle drug administration apparatus and a preparation method therefor. The apparatus comprises substrates, microneedle arrays, and a liquid-absorbing swelling material. Each substrate carries a microneedle array, and the liquid-absorbing swelling material is placed between the substrates to form a sandwich structure. The apparatus uses a mild water absorption and swelling mechanism and the natural peristaltic behavior of the gastrointestinal tract to pierce the intestinal wall using the microneedles to complete drug delivery. The present disclosure physically breaks through the physiological barrier of oral delivery and absorption of biological drugs, improving the oral availability of biological drugs. All materials used are biodegradable soft materials, which are highly safe.
Owner:TSINGHUA UNIVERSITY

Angiotensin converting enzyme inhibitory peptide as well as screening method and application thereof

The invention belongs to the field of bioactive peptides. The invention provides an angiotensin converting enzyme inhibitory peptide as well as a screening method and application thereof. The amino acid sequence of the inhibitory peptide is GKGLW and / or GDGLKW. According to the screening method of the ACE inhibitory peptide, the soybean protein is taken as a raw material, and the ACE inhibitory peptide is prepared and screened by adopting a targeted alkaline protease and chymotrypsin double-enzymolysis technology, so that rapid screening of the ACE inhibitory peptide is realized, and an experimental basis is provided for the structure-function relationship of the ACE inhibitory peptide. The inhibitory peptide provided by the invention has strong antihypertensive activity, high safety and no toxic or side effect. Digestive tract stability determination shows that the inhibitory peptide has good gastrointestinal tract stability in gastrointestinal tract digestion, and can still keep good activity after entering blood.
Owner:EAST CHINA NORMAL UNIV

Method and system for dynamically predicting risk of harm of feed mycotoxin to livestock and poultry

The invention relates to the technical field of artificial intelligence, and discloses a method and a system for dynamically predicting the risk of harm of feed mycotoxin to livestock and poultry. The method comprises the following steps: constructing a metabolic digital twin model based on a multi-organ coupling dynamics mechanism, connecting a gastrointestinal tract, a liver and a kidney through blood flow parameters to form a closed loop topology network, establishing a toxin migration rate equation, and verifying bioavailability; collecting feed toxin concentration and livestock and poultry physiological data in real time; after distributing the initial toxin load, iteratively generating target organ dynamic concentration distribution by adopting a Runge-Kutta method; an organ exposure index is calculated based on an organ specific hazard threshold, key organs are positioned, and low / high risk levels and toxin accumulation paths are output. The method solves the problems that a traditional static model is low in efficiency and poor in organ difference adaptability when being used for dynamically predicting the risk of harm to livestock and poultry caused by feed mycotoxin.
Owner:INST OF ANIMAL HUSBANDRY & VETERINARY MEDICINE ANHUI ACAD OF AGRI SCI

Composition capable of penetrating intestinal barrier during oral administration and application thereof

The invention provides a composition capable of penetrating an intestinal barrier by oral administration. The composition contains a carrier or an auxiliary material of a targeted Microflod cell Dectin-1 receptor, and one or / and a plurality of medicinal components / components, wherein the carrier or the auxiliary material of the target Microflood cell Dectin-1 receptor is beta-glucan, and the carrier or the auxiliary material of the target Microflood cell Dectin-1 receptor is beta-glucan. The effective components / components are traditional Chinese medicine effective components / components, or / and probiotics, or / and chemical medicine components, or / and biological medicines. The invention relates to a composition capable of realizing oral administration and penetrating through an intestinal barrier, which is based on the discovery of the inventor that the composition reaches colon through gastrointestinal tracts, targets colon Microflood cells, is taken by the Microflood cells, penetrates through the intestinal barrier and enters immune tissue Colonic Patches of a colon submucosa. Based on the research, the composition disclosed by the invention can be used for treating various diseases, such as ulcerative colitis, Crohn's disease, colon cancer, rheumatoid arthritis or bacterial pneumonia after being orally taken and absorbed by rectum.
Owner:CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE

Phytobacterium plantarum YYY01 and application thereof in anti-inflammation and production of gamma-aminobutyric acid

The invention belongs to the technical field of biological medicines, and particularly relates to a plant lactobacillus YYY01 strain and application thereof in anti-inflammation and production of gamma-aminobutyric acid. The preservation number of the plant lactobacillus YYY01 provided by the invention is GDMCC (China General Microbiological Culture Collection Center) NO: 65147. The plant lactobacillus YYY01 has relatively good biological safety, relatively good survival in a gastrointestinal tract environment and certain intestinal tract adhesion capacity; the plant lactobacillus YYY01 can produce gamma-aminobutyric acid at high yield, and has the effects of resisting inflammation, regulating intestinal flora and enhancing immune barrier. Good application prospects are shown in the aspects of improving the yield of gamma-aminobutyric acid and preparing products containing gamma-aminobutyric acid.
Owner:JIANGNAN UNIV +1

PVT improvement-based self-attention endoscopic polyp segmentation method

The invention discloses an improved self-attention endoscopic polyp segmentation method based on PVT, and the method comprises the steps: collecting a plurality of gastrointestinal tract images, and carrying out the preprocessing and marking of the images, and obtaining image data and real labels; inputting the image data into a feature extraction network based on PVT and a space channel self-attention module to obtain multi-scale features; inputting the multi-scale features into a multi-scale cross fusion module to obtain four fused feature maps; inputting the fused feature map into a decoder to obtain two prediction maps; inputting the real labels into a decoder to obtain two real labels, and respectively carrying out loss calculation and iterative optimization on the two real labels and the prediction maps with the corresponding sizes; and recovering the two prediction images to the size of the input image, and adding the two prediction images to obtain an endoscopic polyp segmentation model. The invention relates to the technical field of medical image segmentation, and solves the technical problem that the detection precision of a small polyp region and a polyp with a highly fuzzy edge is not high in the existing method.
Owner:ANHUI UNIVERSITY OF TECHNOLOGY +1

Magnetic control bistable soft capsule robot and driving method thereof

The invention belongs to the field of magnetic control capsule robots, and particularly discloses a magnetic control bistable soft capsule robot and a driving method thereof, and the capsule robot comprises a first assembly and a capsule shell; a substance exchange channel is arranged on the capsule shell; the first assembly is arranged in the capsule shell; the first assembly comprises a bistable hemispherical shell and a first magnetic garment which are both of a magnetic soft body structure. The bistable hemispherical shell comprises a first stable state configuration and a second stable state configuration, and elastic potential energy is stored in the first stable state configuration; the steady-state configuration conversion direction of the hemispherical shell is perpendicular to the length direction of the capsule shell; when the hemispherical shell is in the first steady state configuration, the first magnetic garment is arranged on the top end side of the hemispherical shell, and the opening side of the hemispherical shell serves as a carrying cavity; the magnetization direction of the bistable hemispherical shell in the first steady state configuration is diverged towards the periphery with the center of the bottom of the opening side as the center, and the magnetization direction of the first magnetic clothes is the same as the protruding direction of the hemispherical shell. By means of the capsule robot, it is guaranteed that the medical function of the capsule robot is stably achieved in the complex gastrointestinal tract environment.
Owner:HUAZHONG UNIV OF SCI & TECH

Polypeptide hydrogel based on oxidized ganoderan and application

The invention discloses polypeptide hydrogel based on oxidized ganoderan and application. The polypeptide hydrogel is simple in preparation method, rapid in gelling, good in stability and capable of resisting oxidation activity and inhibiting tyrosinase activity. The polypeptide hydrogel provides a physical barrier for the bioactive peptide, so that the influence of the gastrointestinal tract environment is overcome, 71% of polypeptide is released in the intestinal tract, the bioavailability of the peptide is improved, and the problem that the use condition of the polypeptide is limited is effectively solved.
Owner:ZHEJIANG UNIV OF TECH

Intelligent gastrointestinal tract postoperative complication early warning system and method thereof

The invention relates to the technical field of medical information systems, in particular to an intelligent gastrointestinal tract postoperative complication early warning system and a method thereof.The intelligent gastrointestinal tract postoperative complication early warning system comprises a data acquisition module, a data preprocessing module, a deep learning model module in communication connection with the data acquisition module, and a knowledge distillation module in communication connection with the data preprocessing module; the expert knowledge fusion module is in communication connection with the deep learning model module and is used for fusing expert knowledge into a mixed deep learning model; generating a lightweight prediction model; the dynamic weight adjustment module is in communication connection with the deep learning model module and the knowledge distillation module; the multi-task learning module is in communication connection with the deep learning model module; the early warning output module is in communication connection with the knowledge distillation module and the multi-task learning module and is used for generating complication risk early warning based on an output result of the lightweight prediction model; an early warning result and interpretive analysis are displayed through a visual interface, so that the early warning accuracy is improved, and more comprehensive patient state evaluation is provided for doctors.
Owner:XINGAN LEAGUE PEOPLES HOSPITAL

Application of bifidobacterium animalis subsp. Lactis or composition in preparation of product for preventing and / or treating metabolic diseases

The invention relates to an application of a bifidobacterium animalis subsp. Lactis BGI-N3 (the preservation number is CCTCC (China Center For Type Culture Collection) NO: M20221585) or a composition containing the bifidobacterium animalis subsp. Lactis BGI-N3 as an active ingredient in the preparation of a product for preventing and / or treating metabolic diseases, and particularly relates to an application of the bifidobacterium animalis subsp. Lactis BGI-N3 or a composition containing the bifidobacterium animalis subsp. Lactis BGI-N3 as an active ingredient in the preparation of a product for preventing and / or treating metabolic diseases. The bifidobacterium animalis subsp. Lactis comprises a 16S rDNA (ribosomal deoxyribonucleic acid) sequence as shown in SEQ ID NO: 1. The animal bifidobacterium subsp. Lactis BGI-N3 provided by the embodiment of the invention has good safety and excellent gastrointestinal tract environment tolerance, and can effectively reduce the food calorie conversion rate, regulate the systemic chronic inflammation level and improve the fat accumulation condition so as to prevent and / or treat metabolic diseases, such as obesity.
Owner:BGI PRECISION NUTRITION (SHENZHEN) TECHNOLOGY CO LTD

Metal ion-mediated composite polysaccharide-based steady-state probiotic loading body as well as preparation method and application thereof

The invention discloses a metal ion-mediated composite polysaccharide-based steady-state probiotic loading body as well as a preparation method and application thereof, and belongs to the technical field of microorganisms. Sodium alginate and metal ions are coordinated and self-assembled through interaction of non-covalent supramolecules to form a metal ion-alginate skeleton network, functional guar gum is further filled, nano-scale aggregates are pushed to be spontaneously deposited on the surfaces of thalli, and a compound polysaccharide coating with excellent adhesion performance and steady-state performance is generated, so that the stability of the composite polysaccharide coating is improved. The independent coating of the probiotics is realized. The presence of metal ions increases the affinity of the biological material to the coated probiotics, and guar gum endows the probiotic delivery system with good adhesion characteristics. According to the probiotic loading body, the operation steps of an existing cell surface modification technology are simplified, the density is improved while the usage amount of biological materials is reduced, cells can be protected from being damaged by the gastrointestinal tract stress environment so as to maintain the activity of probiotics, and the colonization capacity and the biological activity of the probiotics in the intestinal tract are improved.
Owner:OCEAN UNIV OF CHINA

Protease preparation for preventing pet hair ball disease as well as preparation method and application thereof

The invention discloses a protease preparation for preventing pet hair ball disease as well as a preparation method and application thereof, and belongs to the technical field of pet nutrition and health. The protease preparation for preventing the pet hair ball disease is mainly prepared from a compound enzyme, vitamins, trace elements, dietary fibers, probiotics, meat powder and a wall material, and the mass ratio of the compound enzyme to the vitamins to the trace elements to the dietary fibers to the probiotics to the meat powder to the wall material is (1-100): (0.1-1): (0.1-10): (1-70): (0.1-10): (10-60): (10-60). The protease preparation provided by the invention can effectively degrade hair and indigestible food, prevents the hair and food residues from forming pellets to block gastrointestinal tracts, prevents hair bulb syndrome from occurring in mechanism, and is simple in preparation process and wide in application prospect.
Owner:RIP HI-TECH (TIANJIN) BIOTECHNOLOGY CO LTD

Lactobacillus casei, probiotic preparation for reducing generation of VSCs and application of probiotic preparation

The invention discloses a lactobacillus casei KC88, and the preservation number of the lactobacillus casei KC88 is CGMCC (China General Microbiological Culture Collection Center) No.32107. Meanwhile, the invention also discloses a screening process and application of the strain. According to the lactobacillus casei KC88 provided by the invention, the expression of a Cdl gene with fusobacterium nucleatum can be down-regulated, and the expression of a Mgl gene of porphyromonas gingivalis can be down-regulated. At the same time, the lactobacillus casei KC88 can inhibit the production of pathogenic bacteria biological membranes and reduce the production of volatile sulfides. And the inactivated surface protein of the casei casei KC88 can inhibit the formation of a pathogenic bacterium biological membrane. Therefore, the lactobacillus casei KC88 viable bacteria and the thermally inactivated bacteria have the effects of relieving breath and improving gastrointestinal functions, and can be applied to the fields of medicines, health care products and the like.
Owner:HUNAN NUTRITION TREE BIOTECHNOLOGY CO LTD

Ultrasonic virtual simulation nursing teaching platform for gastrointestinal tract

The invention relates to the technical field of gastrointestinal tracts, in particular to a gastrointestinal tract ultrasonic virtual simulation nursing teaching platform which comprises a function module and a hardware configuration module. The function module comprises an anatomy learning module, an ultrasonic simulation module, a case training module and an examination and evaluation module; the hardware configuration comprises a VR head-mounted display, an ultrasonic simulator and an operation panel. The system has the advantages of safe and risk-free training, standardized process learning, immersive scene experience and instant feedback evaluation, a high-fidelity gastrointestinal tract ultrasonic virtual simulation teaching platform for critically ill patients is constructed, a 3D virtual model is constructed by using a virtual simulation technology, knowledge is presented dynamically and visually, real situations such as ICU wards and the like are simulated through VR, and real-time feedback evaluation of the gastrointestinal tracts of the critically ill patients is realized. The learning initiative and the sense of participation are stimulated; an ICU environment is virtualized, an unlimited'trial-and-error 'practice space is provided, the equipment cost is reduced, potential safety hazards are avoided, and space-time and safety barriers are broken.
Owner:SUZHOU NINTH PEOPLES HOSPITAL (SUZHOU WUJIANG DISTRICT FIRST PEOPLES HOSPITAL)

Microbial functional factor evaluation system and method based on data analysis

The invention relates to the technical field of biological big data analysis, in particular to a microbial functional factor evaluation system and method based on data analysis, and the method comprises the following steps: extracting microbial community DNA, obtaining first sequencing data through a high-throughput sequencing technology, and preprocessing the first sequencing data to obtain second sequencing data; evaluating a functional characteristic index of the microbial community based on the second sequencing data; determining a functional factor of the microbial community based on the functional characteristic index; and constructing a functional factor prediction model, and predicting the influence of the gastrointestinal tract environment change on the functional characteristics of the microbial community by evaluating the change trend of the functional factor under different gastrointestinal tract environment conditions. The functional factors of the microbial community are determined through the functional characteristics of the microbial community, and the functional factor prediction model is constructed, so that the reliability and the accuracy of prediction of the functional characteristics of the microbial community by gastrointestinal tract environment change are improved.
Owner:HEFEI UNIV OF TECH

Enteral tube system and methods of use

The present invention pertains to the field of medical devices and introduces an enteral tube system designed for efficient and continuous delivery of fluids into a patient's gastrointestinal tract. The system integrates a one-way air valve along the tubular body, allowing ambient air to equalize negative pressure within the tube. This innovative feature enables the plunger of a syringe connected to the syringe port to be removed and the syringe refilled without disconnecting it, ensuring uninterrupted operation. The system also includes an enteral connector with user-controlled fluid flow pathways, enhancing versatility and precision during fluid administration. By addressing challenges such as negative pressure buildup and simplifying the refilling process, the invention reduces handling complexity and improves overall efficiency. The system is suitable for administering enteral fluids, medications, or diagnostic agents in healthcare settings, offering significant advantages over traditional enteral feeding systems.
Owner:FABRIGAS FRANCIS PALMA

Methods of diagnosis and treatment of epilepsy based on gastrointestinal microbiota alterations

The application relates to methods of diagnosis of status epilepticus (SE) or new onset refractory status epilepticus (NORSE), as well as determining the likelihood of mortality associated with SE and / or NORSE, based on mammalian gastrointestinal (GI) microbiota. The application further relates to the treatment or prevention of SE and / or NORSE, or mortality associated with these conditions via use of probiotics, prebiotics, compounds and / or compositions for modulating the GI microbiota.
Owner:NEW YORK UNIV

Therapeutic systems and methods using electroporation

Devices, systems, and methods described in this disclosure can be used to deliver electroporation and adjunct therapies to treat anastomotic leaks and the resulting abscess cavities around the GI tract, within the thoracic cavity, and elsewhere within the human body. The thermal or non-thermal electroporation therapy can be delivered using the devices, systems, and methods described herein. In some embodiments, the electroporation energy is delivered to achieve sterilization and promote healing of spaces such as abscess cavities.
Owner:MAYO FOUNDATION FOR MEDICAL EDUCATION & RESEARCH

Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis

The present invention is directed to orally administered compositions of topically acting corticosteroids for the treatment of inflammation of the gastrointestinal tracts such as eosinophilic esophagitis. The present invention also provides a method for treating conditions associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention as orally disintegrating tablets comprising a topically active corticosteroid adsorbed onto a pharmaceutically acceptable carrier such as silicified microcrystalline cellulose.
Owner:ELLODI PHARM LP